Cardiovascular Disease in Patients with Schizophrenia
Schizophrenia is a chronic, heterogeneous neuropsychiatric illness that is among the world’s top 20 causes of long term disability.
This module provides an evidence-based overview of national and international data on the prevalence and risk factors for cardiovascular disease (CVD), the contributory effects of antipsychotic drugs to cardiovascular risk, and the potential cardiotoxicity associated with clozapine treatment.
It presents local experiences with a shared model of care and discusses the potential of such models to reduce the cardiovascular risk burden in patients with schizophrenia.
Medical Journal of Australia
Reading: journal; textbook; book; literature review
1h : 0m
MBA: 1h : 0m
Medical Practitioner, Medical Student, Doctor-in-Training, Non-Vocationally Registered, Nurse / Midwife, Researcher, Retired, Specialist - Other, Specialist General Practitioner